2-amino-5-phosphonovalerate has been researched along with galantamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ivanov, VB; Schilström, B; Svensson, TH; Wiker, C | 1 |
Imoto, K; Miyata, M; Nagumo, Y; Takeuchi, Y | 1 |
2 other study(ies) available for 2-amino-5-phosphonovalerate and galantamine
Article | Year |
---|---|
Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors.
Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Analysis of Variance; Animals; Cholinesterase Inhibitors; Donepezil; Dopamine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Galantamine; Indans; Male; Mecamylamine; Microdialysis; Neurons; Nicotinic Antagonists; Piperidines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Synaptic Transmission; Ventral Tegmental Area | 2007 |
Synapse- and subtype-specific modulation of synaptic transmission by nicotinic acetylcholine receptors in the ventrobasal thalamus.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Acetylcholine; Animals; Animals, Newborn; Bicuculline; Cholinesterase Inhibitors; Dihydro-beta-Erythroidine; Dimethylphenylpiperazinium Iodide; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA-A Receptor Antagonists; Galantamine; Glycine; In Vitro Techniques; Mice; Mice, Inbred C57BL; Neural Inhibition; Neurons; Nicotinic Agonists; Patch-Clamp Techniques; Receptors, Nicotinic; Sodium Channel Blockers; Somatosensory Cortex; Synapses; Synaptic Transmission; Tetrodotoxin; Thalamus; Valine | 2011 |